Incidental and symptomatic renal tumors: impact on patient survival by Dall'Oglio, Marcos Francisco et al.
○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○
ABSTRACT
O
ri
gi
na
l A
rt
ic
le
○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○
INTRODUCTION
The incidence of renal cell carcinoma
(RCC) and the diagnosis of localized tumors
are increasing.1,2 It was predicted that the
worldwide mortality due to RCC would reach
100,000 cases in the year 2000.3 The risk of
RCC after the age of 40 years is 1.34%, and
the risk of death is over 0.5%.4
The most common symptoms are hema-
turia, low back pain and palpable mass, and
these events occur in isolation in 35-59%,
34-41% and 30-45% of the cases, respec-
tively.5-7 The 5-year survival rate for sympto-
matic tumors is 30-83% while for  inciden-
tal tumors it is 83-95%8-13 and, according to
tumor staging, the rate is 91% for PT1, 74%
for PT2, 67% for PT3 and 32% for PT4.14
Metastatic disease is seen in 25-40% of the
cases at diagnosis,15,16 with a 5-year survival
rate of 13%.17
Twenty years ago, the incidental case rate
was less than 5%, but there has been an in-
crease of more than 50% in early diagnosis
up to the present day, due to the advent of
non-invasive radiological techniques such as
ultrasonography and computerized tomogra-
phy (CT) scans. This has allowed small lesions
with favorable prognosis and low incidence
of metastasis to be discovered.8,18,19
Nonetheless, there are no indications of
methods for predicting the behavior of small
tumors discovered incidentally.20 Many au-
thors question the factors that might influ-
ence the behavior of such neoplasia, believing
that incidental tumors may display biological
behavior that differs from that of symptomatic
tumors.8,21,22 Would there be a lower degree
of malignity and/or slower growth?23
Looking for answers to such questions,
this study had the objective of analyzing the
survival of patients with incidental and symp-
tomatic RCC.
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METHODS
A retrospective non-controlled study was
made of 128 patients who underwent renal
surgery for RCC between January 1988 and
July 1999, with the operation being performed
by the same group of surgeons. From this, 115
patients were selected. Their mean age was
59.1 years (range: 9-87) and the median was
60 years, and there were 86 males (74.8%)
and 29 females (25.2%).
The complementary diagnostic tests that
confirmed the extensive renal lesion were ul-
trasonography, excretory urography, CT scan,
nuclear magnetic resonance and  arteriography.
Criteria for inclusion and exclusion
All patients operated on for RCC who had
complete files were included. Thirteen patients
were excluded, because of insufficient data and
pathological material for eight patients, fol-
low-up of previous RCC in four cases, and
von Hippel-Lindau disease in one case.
The follow-up was undertaken from the
consultation office. When more than three
months had elapsed since the preceding con-
sultation, telephone calls was made to in-
quire about the patient’s current status. In
this follow-up, consultations took place
every three months during the first year,
semiannually from the second to the fifth
year and yearly thereafter.
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CONTEXT: Renal cell carcinoma is the third most fre-
quent genitourinary neoplasia, and there is cur-
rently an increase in the incidental diagnosis of
tumors confined to the kidneys.
OBJECTIVE: To study the survival of patients with inci-
dental and symptomatic renal tumors who have
undergone nephrectomy.
DESIGN: Retrospective.
SETTING: Hospital Sírio Libanês and Beneficência
Portuguesa de São Paulo.
PARTICIPANTS: 115 patients with diagnosis of renal
cell carcinoma, operated on by the same group of
surgeons and evaluated by a single pathologist.
MAIN MEASUREMENTS: Sex, age and diagnosis
method, analyzed in two groups, according to the
tumor diagnosis: Group 1 with incidental diagno-
sis and Group 2 with symptomatic tumors. The
anatomopathological characteristics and patient
survival in both groups were evaluated. A statisti-
cal analysis was performed using the Student t,
chi-squared, log rank and Kaplan-Meyer tests.
RESULTS: Among the studied patients, 59(51%) had
an incidental diagnosis, with 78% diagnosed by
ultrasonography, 20% by computerized tomog-
raphy scan and 2% during surgeries; 56 patients
(49%) were symptomatic. Tumor locations were
equally distributed between the two kidneys, and
the surgery was conservative for 24% of the inci-
dental and 9% of the symptomatic group. In the
incidental group only one patient had tumor pro-
gression and there was no death, while in the
symptomatic group there were 5 progressions and
10 deaths. The 5-year specific cancer-free survival
was 100% in the incidental and 80% in the symp-
tomatic group (p = 0.001) while the disease-free
rate was 98% in the incidental and 62% in the
symptomatic group (p < 0001).
CONCLUSION: Incidental renal tumor diagnosis of-
fers better prognosis, providing longer disease-
free survival.
KEY WORDS: Carcinoma. Renal. Cell. Diagnosis. In-
cidental. Survival.
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Evaluation criteria
The reason that led the patient to the doc-
tor was identified and the patients were di-
vided into two groups, according to the diag-
nosis of the primary tumor.
1. Incidental: patients with findings of ex-
tensive renal lesion identified in radiologi-
cal examinations at routine health check-
ups or because of complaints unrelated to
RCC.
2. Symptomatic: patients with symptoms
related to RCC.
The patients were followed up for peri-
ods ranging from 2 to 138 months, with a
median of 26 months for incidental cases and
33 months for symptomatic cases.
Statistical analyses
Statistical analyses were performed via the
Student t and chi-squared tests. The specific
cancer-free survival and disease-free rates were
calculated using the Kaplan-Meyer curves and
the log rank test was used to compare differ-
ences in the survival of the groups. The statis-
tical significance level utilized was p < 0.05.
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RESULTS
In the incidental group there were 59 pa-
tients (51%) and in the symptomatic group,
56 (49%). The lesions of the incidental group
were identified by ultrasonography in 46 pa-
tients (78%), by CT scan in 12 (20%) and one
case was identified during the operation (2%).
The male to female ratios were, respec-
tively, 45:14 in the incidental and 41:15 in
the symptomatic group. The mean ages of
males and females were, respectively, 62.7/
57.2 in the incidental and 57.2/55.0 in the
symptomatic group (non-significant).
In the incidental group, 45 radical (76%)
and 14 conservative (24%) surgeries were per-
formed, while in the symptomatic group 51
radical (91%) and 5 conservative (9%) ne-
phrectomies were performed.
The dominant cell type was clear cells in
59% (68), chromophile cells in 23% (26),
chromophobe in 10%, and sarcomatous in 8%.
When the tumor size was related to the
type of clinical presentation, it was noticed that
lesions of between 0.5 and 4 cm were present
in 30 (51%) of the incidental and 11 (20%) of
the symptomatic cases; between 4.1 and 7 cm
in 21 (36%) and 22 (39%); between 7.1 and
10 cm in 5 (8%) and 14 (25%); and tumors
greater than 10 cm in 3 (5%) and 9 (16%),
respectively (p = 0.001). The mean tumor size
was 4.6 ± 2.3 cm (range 0.5 to 13) in the inci-
dental and 7.3 ± 3.6 cm (range 1.5 to 19.5) in
the symptomatic group (p = 0.001).
Table. Survival situation at the end of the study, according to the presentation.
Situation at the end of the study Incidental group Symptomatic group Total
Alive, without evidence of disease 54 36 90
Alive, with disease 1 5 6
(progression of disease)
Death due to the kidney cancer 0 10 10
Death due to other causes 4 1 5
(unrelated to the disease)
Lost from the follow-up 0 4 4
Total 59 56 115
Figure 1. Reasons for consultations sought by patients with incidental diagnosis.
Figure 2.  Reasons for urological consultations sought by patients with incidental diagnosis.
Figure 3. Reasons for consultations sought by patients in the symptomatic group.
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With regard to the pathological staging,
among the incidental cases there were 47 pa-
tients in stage PT1, 5 in stage PT2 and 7 in
stage PT3. Among the symptomatic cases there
were 27 patients in stage PT1, 11 in stage PT2,
10 in stage PT3 and 8 in stage PT4 (p < 0.001).
The reasons for consultations sought with
different specialties are seen in Figure 1, and
subsequently the urological consultations were
separated out (Figure 2). The main complaints
in the symptomatic group are seen in Figure
3. Complaints were balanced with regard to
which of the kidneys was involved and the
presentation.
By the end of the study, only one patient
in the incidental group showed progression
of the disease and there was no death, while
in the symptomatic group there were five
progressions and 10 deaths. Only four patients
were lost during the follow-up period of 2 to
138 months (Table).
The specific cancer-free survival (p =
0.001) and disease-free survival (p < 0.001)
are shown in Graphics 1 and 2 respectively.
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DISCUSSION
This study shows that incidental tumors
have a better prognosis and provided longer
disease-free survival then the symptomatic
tumors did during the period analyzed. Al-
though this study was retrospective, 96.6%
of the patients were followed up and thus the
results can be considered reliable.
Several authors have reported high per-
centages of incidental tumors identified via
ultrasonography, with rates of 38%-97%.24-28
In this study, 78% of the diagnoses were made
by ultrasound and 20% by CT scan. These
data show that the ultrasonography examina-
tion has an important role in the early detec-
tion of such tumors, considering that it is used
for evaluating cardiac, hepatic, gallbladder,
pancreas and gynecological diseases as well as
in routine health check-ups. Currently, two-
thirds of incidental tumors are found by other
physicians, in non-urological situations.25,29
The finding of a 50% incidental diagnosis rate
in this study is probably due to the fact that
the research was performed in a specialized
clinic. In the present study, tumor location
was equally distributed between the two kid-
neys, but some series have shown greater num-
bers of incidental cases in the right kid-
ney.24,26,27
Currently, large centers defend the use of
some type of screening.9 The screening of high
risk populations, especially for those undergo-
ing dialysis or with von Hippel-Lindau disease,
and for those over 50 years of age, is advised.30,31
On the other hand, some other groups reject
this approach in the belief that the cost/benefit
relationship of such screening is not well de-
fined.24,25,32 However, rapid routine examina-
tion of the kidneys during ultrasonography of
other organs is also defended.25,33
Hematuria was the main complaint in the
symptomatic cases, in 47% of the cases in this
study, and only one patient showed the classi-
cal triad (hematuria, back pain and palpable
mass) that in the past was seen in 10% of cases5
and is now only rarely seen.30
In the last few years there has been an in-
crease in the detection of incidental tumors,18
directly related to the use of imaging exams,
especially ultrasonography and CT scans.18,34,35
The “internist’s tumor”36 can thus be renamed
the “radiologist’s tumor”,30 because of the iden-
tification of RCC at its early stages, thereby
increasing the apparent disease prevalence.37
These tumors are frequently small and found
in routine examinations and evaluations of
other diseases,38,39,40 with greater incidence
among younger males and females with a use-
ful working life.25 Considering that RCC oc-
curs in the proportion of 3:1 for men to
women, in the fifth and sixth decades of life,
most of these patients might be diagnosed by
their own urologist. The practical implication
Graph 1. Specific cancer-free survival curve according to presentation.
Log rank test: c2
1gl
 = 10.16; p = 0.001; Incidental group = (------) dotted line; Symptomatic group = (——) full line
Graph 2. Disease-free survival curve according to presentation.
Log rank test: c2
1gl
 = 12.48; p < 0.001; Incidental group = (------) dotted line; Symptomatic group = (——) full line
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CONTEXTO: O carcinoma de células renais é a
terceira neoplasia geniturinária em frequência,
havendo atualmente um aumento no diag-
nóstico incidental de tumores restritos ao rim.
OBJETIVO: Verificar a sobrevida dos pacientes
com tumores de rim incidentais e sintomáti-
cos submetidos a nefrectomia.
TIPO DE ESTUDO: Retrospectivo.
LOCAL: Hospital Sírio Libanês e Beneficência
Portuguesa de São Paulo.
PARTICIPANTES: 115 pacientes com diagnós-
tico de carcinoma de células renais e opera-
dos por um mesmo grupo de cirurgiões, ava-
liados por um único patologista.
VARIÁVEIS ESTUDADAS: Sexo, idade e mé-
todo diagnóstico, analisados em dois grupos
conforme o diagnóstico do tumor: Grupo 1
com diagnóstico incidental e Grupo 2, com
tumores sintomáticos. São também avaliadas
as características anatomopatológicas da peça
operatória e sobrevida dos pacientes nestes
dois grupos. Foi realizada análise estatística
através do teste t de Student, qui quadrado,
log rank test e Kaplan-Meyer.
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RESULTADOS: Dos pacientes estudados, 59
(51%) tinham diagnóstico incidental, sen-
do 78% diagnosticados pelo exame ultra-
sonográfico, 20% por tomografia computa-
dorizada e 2% em transoperatório; já 56 pa-
cientes (49%) apresentaram-se sintomáticos.
Houve um equilíbrio quanto à lateralidade,
sendo a cirurgia conservadora em 24% dos
incidentais e 9% dos sintomáticos. No gru-
po incidental, apenas um paciente teve pro-
gressão e nenhum óbito, ao passo que os sin-
tomáticos tiveram 5 progressões e 10 óbi-
tos. A sobrevida câncer-específica em cinco
anos foi de 100% para incidentais e 80%
para os sintomáticos (p = 0,001) e a
sobrevida livre de doença foi de 98% para
os incidentais e 62% para os sintomáticos
(p < 0,001).
CONCLUSÃO: O tumor de rim diagnosticado
incidentalmente oferece melhor prognóstico,
proporcionando maior sobrevida livre de
doença.
PALAVRAS-CHAVE: Carcinona. Célula. Renal.
Diagnóstico. Incidental. Rim.
of this study is that incidental diagnosis of
renal carcinoma will dramatically change the
prognosis for patients with RCC, offering a
real possibility of cure for most patients.
In a study by Nakano et al.,23 incidental
diagnosis was more prevalent among the eld-
erly, which can be related to the lower de-
gree of malignity and slower growth of RCC.
In the present series, there was no statistical
difference regarding age at diagnosis, for ei-
ther group.
In the incidental group, conservative sur-
gery was performed in 24% of the cases, while
this was done in 9% of the symptomatic cases.
Such surgery was performed in tumors smaller
than 4 cm, in accordance with advice in the
literature,41,42 with no recurrence. Obviously,
the difference in the use of conservative sur-
gery between the groups is justified by the
smaller size of incidental tumors, which forms
an indication for preservation of the renal unit.
The 5-year survival rate found in dif-
ferent studies for asymptomatic and symp-
tomatic patients is, respectively, 83-95%
and 30-83%.8-13 In the present series, by the
end of the study period, in the incidental
group there was only one case of progres-
sion, while among the 56 patients in the
symptomatic group, 5 showed progression
and 10 died. The probability of disease-free
survival after 5 and 9 years was respectively,
98% and 98% for the incidental group and
62% and  53% for the symptomatic group
(p < 0.001).
It has been shown that 80% of RCC
metastases occur by the third year of follow-
up.43 With this in mind and with the objec-
tive of more clearly showing the survival in
time units, a cutoff was established for patients
with a follow-up equal to or longer than 30
months. This confirmed the better survival
curves for the incidental group (p < 0.001).
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CONCLUSION
RCC that is found incidentally offers a
better prognosis for patients because it pro-
vides for longer disease-free survival.
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